达利雷生不同版本一盒的最新价格公布

Introduction: Daridorexant, also known as daridorexant, is a drug called an orexin receptor antagonist. It was approved by the FDA in 2022 for the treatment of insomnia or difficulty sleeping. It can be used to treat people who have difficulty falling asleep or staying asleep throughout the night. Dalitraxen blocks a chemical called orexin. By blocking orexin, Dalilaxen can help patients fall asleep and stay asleep.

The latest price of a box of different versions of DaliRasen is announced

Currently, only one version is known. The pharmaceutical manufacturer is Idorsia Ltd/Switzerland Alschwil Company. The specification of this version of DaliRasen is 50mg*20 tablets/box, and the price of a box is about 3000$-3600$.

May vary depending on region, purchasing channel and other factors, and may change with market and policy changes. If you need to know the latest price of DaliRasen, it is recommended to consult Simcere Pharmaceuticals directly or pay attention to the official announcement of the National Medical Products Administration to obtain the most accurate price information.

When purchasing DaliRasen, you should make sure to choose formal channels to ensure the authenticity and quality of the drug.

How to treat insomnia

Dalifex works by blocking the OX1R and OX2R orexin receptors in the brain, causing the body to sleep and wake up at more regular times and feel tired at the right time. Taking Dalitrazen helps a patient's body fall asleep naturally without the need for sedation, which means when they wake up, they feel more rested and alert without being groggy, which is often the result of using sedatives to fall asleep.

The time it takes for DaliRazen to work usually depends on the person taking it, some people may experience improved sleep within a few days, while others may take longer.

Precautions for the use of Dalilaysan

1. Avoid eating grapefruit or drinking grapefruit juice at night while taking Dalilayson.

2. Elderly patients (>65 years old) do not need to adjust the dose. However, due to limited data on patients over 75 years old, Dalilaysan should be taken with caution.

3. Dalilaysan is contraindicated in patients who are allergic to the active substance or any of its excipients, patients with narcolepsy, and patients using strong CYP3A4 inhibitors.

4. Unless the patient feels fully awake, potentially dangerous activities should be avoided, especially in the first few days of treatment.

5. It is recommended to be cautious in the use of DaliRaxen and drugs and alcohol that depress the central nervous system.

DaliRasen produced significant improvements in objective measures of sleep onset and sleep maintenance, as well as in patient-reported total sleep time. If you forget to take Dalitrazolin at bedtime, do not take the missed dose in the evening.